The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...

Treatment with intravenous (IV) edaravone was associated with fewer reported disease progression milestones and deaths in patients with amyotrophic ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...

“This move is reckless, basically ordering CDC not to work with WHO to put out fires is going to make Americans far more vulnerable,” Dr Lawrence Gostin, a global health expert at Georgetown ...

HealthDay News — Kansas health officials are tackling the largest tuberculosis (TB) outbreak in US history, with 67 confirmed cases since the start of 2025.

For patients with heart failure (HF), a greater focus on medication management may be needed in order to mitigate HF exacerbations caused by certain ...

“Beneficial pediatric obesity treatment response yielded enduring health benefits, markedly lowering future morbidity and mortality risks in young adulthood,” the authors write. Several authors ...

The updated labeling for Qelbree provides additional information on the pharmacodynamic profile of the drug. Findings show ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

HealthDay News — Heart disease continues to be a leading cause of death, according to a report from the American Heart Association published online January 27 in Circulation.

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes.

HealthDay News — Stimulant dispensing to children aged 5 to 17 years decreased after the start of the COVID-19 pandemic and during a shortage of immediate-release mixed amphetamine salts in October ...